TCM

TCM R&D / Revenue

R&D to Revenue Ratio of TCM (524156.BO) as of Oct 30, 2026.

R&D / Revenue

0.00

Last updated:

R&D to Revenue Ratio of TCM is 2025 0.00 . R&D to Revenue Ratio of TCM was 2024 0.00 . It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

TCM Stock analysis

What does TCM do? TCM Ltd generates revenue through its Solar Division, which focuses on solar energy solutions, and the sale of auto care products and healthcare devices. The company's subsidiary TCM Healthcare Private Limited manufactures and trades SARS-CoV-2 test kits alongside a wide range of medical devices, including surgical, dental, and scientific equipment, as well as PPE kits, sanitizers, and disposable medical instruments. TCM Ltd's business segments target healthcare providers, automotive service centers, and renewable energy sectors, with products distributed through both direct sales and established distribution channels. The firm's healthcare segment includes the sale of medical devices, surgical instruments, and PPE kits, catering to hospitals, clinics, and healthcare facilities. Auto care products are sold to automotive dealerships and service centers, while solar solutions are marketed to energy companies and construction firms involved in renewable energy projects. TCM Healthcare Private Limited operates as a dedicated entity for medical product distribution, ensuring compliance with healthcare regulations and market demands. TCM Ltd's subsidiaries, iSpark Learning Solutions Pvt Ltd and TCM Healthcare Private Limited, support the company's diversified operations. iSpark Learning Solutions Pvt Ltd contributes to educational services, while TCM Healthcare Private Limited handles the medical device and test kit business, ensuring a seamless integration of healthcare product offerings within the company's broader portfolio. TCM is one of the most popular companies on Eulerpool.

Frequently Asked Questions about TCM stock

On Eulerpool you can find the complete historical development of R&D to Revenue Ratio TCM since 2006 – with annual values, charts, and detailed analysis.

The R&D to Revenue ratio shows what percentage of revenue a company invests in research and development. Higher ratios indicate stronger focus on innovation.

A 'good' varies by industry and company stage. On Eulerpool, you can compare R&D to Revenue Ratio's TCM with sector peers and the industry average to assess whether it is attractive.

To evaluate R&D to Revenue Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for R&D to Revenue Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — TCM

All Key Metrics — TCM